How Abbott Is Making Incremental Innovation Count For Patients

Abbott’s innovation and development center in Mumbai has made significant progress in shaping incremental but impactful innovations for India and some international markets. A once-daily formulation of heart failure drug ivabradine has caught the attention of the innovator company too.

Pillai_Raviraj
Abbott Executives Raviraj Pillai And Alexis Roberts-McIntosh

Innovation coming out of Abbott Healthcare's new innovation and development (I&D) center in Mumbai is helping to provide incremental advances in R&D that can have an important impact on care and patient value.

Importantly, this type of innovation - which ranges from new drug delivery methods and dosage combinations to new indications and digital solutions - though locally driven at the outset, is...

More from R&D

More from Scrip